Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PARD $0.19 0.0700 +58.33%
ARIA $9.89 2.9100 +41.69%
EPZM $20.10 2.6000 +14.86%
SNSS $1.21 0.1500 +14.15%
BLRX $1.53 0.1700 +12.50%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CCXI $6.50 -0.3900 -5.66%
NWBO $8.11 -0.1900 -2.29%
PGNX $7.67 -0.1600 -2.04%
VBLT $5.31 -0.1100 -2.03%
PFE $32.66 -0.6000 -1.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

Immune Design Announces Phase 2 Cancer Immunotherapy Trial Collaboration

(StreetInsider) Aug 12, 2015 - Plan to evaluate combination of CMB305 and Genentech's atezolizumab in patients with soft tissue sarcoma.
read article 

BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma

(CNBC) Aug 10, 2015 - BioClin Therapeutics, Inc. announced today that it has initiated a Phase 2 clinical study of B-701, an anti-FGFR3 antibody being investigated for the treatment of locally advanced or metastatic urothelial cell carcinoma, also known as bladder cancer.
read article 

Oxygen Treatment Boosts The Success Of Umbilical Cord Blood Transplants

(University of Kansas Cancer Center) Aug 11, 2015 - A pilot clinical trial shows hyperbaric oxygen treatment gives blood cancer patients safe, simple way to improve their transplant outcome.
read article 

Target Healthy Cells To Stop Brain Cancer “Hijack”: UBC study

(University of British Columbia [Vancouver, Canada]) Aug 12, 2015 - New UBC research into brain cancer suggests treatments should target the cells around a tumor to stop it from spreading.
read press release 

Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy

(UCSF) Aug 10, 2015 - Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological, and psychiatric disorders, might prove useful in cancer therapy, according to research findings in fruit flies and mice by UC San Francisco scientists that led to unconventional treatment of a case of metastatic brain cancer.
read article 

Novel Therapeutic Agent for Pediatric Cancer Developed at UC San Diego in Clinical Trials

(UC San Diego Health) Aug 11, 2015 - Phase I trial to launch at 14 hospitals nationally, first-time used in children.
read press release 

New Combination Treatment Effective Against Melanoma Skin Metastases

(UC Davis) Aug 11, 2015 - In findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.
read press release 

Blood Vessel “Doorway” Lets Breast Cancer Cells Spread Through Blood Stream

(Albert Einstein) Aug 12, 2015 - Using real-time, high-resolution imaging, scientists have identified how a “doorway” in the blood vessel wall allows cancer cells to spread from breast tumors to other parts of the body.
read press release 

Spread of Cancer from Pancreas Arises from the Interactions of Multiple Types of Wayward Cells

(Penn Medicine) Aug 12, 2015 - Tumor cells associated with pancreatic cancer often behave like communities by working with each other to increase tumor spread and growth to different organs.
read press release 

Tell-tale Biomarker Detects Early Breast Cancer In NIH-funded Study

(NIH) Aug 12, 2015 - Researchers have shown that magnetic resonance imaging (MRI) can detect the earliest signs of breast cancer recurrence and fast-growing tumors.
read press release 

AbbVie to Seek Approval For Potential Blockbuster Leukemia Drug

(Reuters) Aug 12, 2015 - AbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its primary goal in a mid-stage trial and that the company would seek U.S. approval of the medicine, which analysts have said has blockbuster sales potential.
read article 

Radiation Costs Vary Among Medicare Patients with Cancer

(UC San Diego Health) Aug 11, 2015 - Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person’s cancer, report University of California, San Diego School of Medicine researchers in the Journal of Oncology Practice.
read press release 

Strep's Evolution May Provide Clues for Developing a Vaccine

(ABC News/Associated Press) Aug 10, 2015 - The same bacteria that cause simple strep throat sometimes trigger bloodstream or even flesh-eating infections instead, and over the years, dangerous cases have increased. Now researchers have uncovered how some strains of this bug evolved to become more aggressive.
read article 

Judge Strikes Down Oklahoma Law Restricting Abortion Drugs

(The Charlotte Observer/Associated Press) Aug 10, 2015 - A judge struck down an Oklahoma law Monday that required doctors to follow label instructions when prescribing abortion-inducing drugs, finding the rule is unconstitutional because it doesn't apply to other kinds of medication.
read article 

High Risk Medical Devices Backed By Few Studies

(Reuters Health) Aug 11, 2015 - Many high-risk therapeutic devices get Food and Drug Administration (FDA) approval with only one study proving their safety and efficacy before going to market.
read article 

IBM Crafts a Role for Artificial Intelligence in Medicine

(Wall Street Journal) Aug 11, 2015 - Deal for Merge Healthcare is step toward training IBM’s Watson software to identify cancer, heart disease.
read article (paid subscription required) 

Battle Over Who Gets $15,000 Heart Drug Focuses on Guidelines

(Bloomberg) Aug 10, 2015 - The fight is intensifying over which patients will get an almost $15,000-a-year cholesterol drug from Regeneron Pharmaceuticals Inc. and Sanofi, with CVS Health Corp. calling for new treatment guidelines to make it clearer who should qualify.
read article 

Physician-Scientist Named Head of Neuro-Oncology at NYU Langone's Laura and Isaac Perlmutter Cancer Center

(NYU Langone) Aug 10, 2015 - NYU Langone Medical Center has announced the appointment of physician-scientist and brain tumor specialist Andrew S. Chi, MD, PhD, as the new chief of Neuro-Oncology for its Laura and Isaac Perlmutter Cancer Center and co-director of the NYU Langone Brain Tumor Center.
read press release 

MD Anderson Names Valerae O. Lewis, M.D., Chair of Orthopaedic Oncology

(MD Anderson) Aug 10, 2015 - Dr. Lewis is internationally recognized for her expertise in pelvic sarcoma surgery and substantial contributions in shaping orthopaedic education throughout the United States, particularly in the area of culturally competent care.
read press release 

OncLive® Joins with Roswell Park Cancer Institute in Strategic Alliance Partnership

(PRWEB) Aug 11, 2015 - OncLive® today announced that it is teaming up with Roswell Park Cancer Institute (RPCI), located in western New York, in OncLive’s Strategic Alliance Partnership program to grow awareness and understanding of RPCI’s efforts to reduce cancer’s impact and provide better outcomes and quality of life for cancer patients.
read press release 

Kids With Cancer Get Futuristic Chance at Saving Fertility

(New York Times/Associated Press) Aug 11, 2015 - Barely 2 years old, Talia Pisano is getting tough treatment for kidney cancer that spread to her brain. She's also getting a chance at having babies of her own someday.
read article 

Planned Parenthood Out of Cancer Screening Program

(The Texas Tribune) Aug 10, 2015 - As part of the GOP's ongoing fight against Planned Parenthood, poor, uninsured women in Texas will soon be unable to obtain government-subsidized breast and cervical cancer screenings at the organization's clinics.
read article 

Biocept and University of California, Irvine to Study Blood-based Liquid Biopsy Testing in Cancer Patients

(Yahoo! Finance) Aug 11, 2015 - Biocept, Inc. today announced a collaboration with the University of California, Irvine to evaluate biomarkers detected from blood-based versus invasive tissue biopsies in patients with metastatic cancers.
read article 

Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October

(StreetInsider) Aug 11, 2015 - Aeterna Zentaris Inc. today announced that the independent Data and Safety Monitoring Board ("DSMB") for the pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer, will complete a pre-specified second interim efficacy and safety analysis of the compound in early October 2015.
read article 

Join Next Week’s HCT Cyber Discussion on the Science of Teamwork

(ASCO in Action) Aug 11, 2015 - The next National Cancer Institute (NCI)-sponsored Healthcare Teams (HCT) Cyber Discussion is scheduled to take place on Monday, August 17, from 1:00 – 2:00 PM EDT. This session is titled, “The Science of Teamwork: Implications for Cancer Care Teams.”
read article